Literature DB >> 15820372

Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician.

Ciarán M Duffy1.   

Abstract

Several groups have undertaken research on health status, functional status, and quality of life in the pediatric rheumatic diseases, particularly juvenile idiopathic arthritis (JIA) and juvenile rheumatoid arthritis. This article highlights the principles involved in this type of measurement, discusses the measures that have been developed for JIA, and describes the outcomes determined from recent retrospective and prospective longitudinal outcome studies. These studies suggest that although there has been improvement in overall outcomes, significant numbers of individuals persist with active disease into adulthood and have significant damage, reduced functional ability, and disability.

Entities:  

Mesh:

Year:  2005        PMID: 15820372     DOI: 10.1016/j.pcl.2005.01.009

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  11 in total

Review 1.  Quality of life in children with systemic lupus erythematosus.

Authors:  L Nandini Moorthy; Margaret Peterson; Karen B Onel; Melanie J Harrison; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

3.  Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Edward H Giannini; Steven J Spalding; Philip J Hashkes; Kathleen M O'Neil; Andrew S Zeft; Ilona S Szer; Sarah Ringold; Hermine I Brunner; Laura E Schanberg; Robert P Sundel; Diana Milojevic; Marilynn G Punaro; Peter Chira; Beth S Gottlieb; Gloria C Higgins; Norman T Ilowite; Yukiko Kimura; Stephanie Hamilton; Anne Johnson; Bin Huang; Daniel J Lovell
Journal:  Arthritis Rheum       Date:  2011-12-19

4.  Outcome measures in pediatric rheumatology.

Authors:  Sujata Sawhney; Manjari Agarwal
Journal:  Indian J Pediatr       Date:  2010-10-12       Impact factor: 1.967

5.  Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.

Authors:  M Halbig; G Horneff
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 6.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 7.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

8.  Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis.

Authors:  Mohamed Hamooda; Hala Fouad; Nermeen Galal; Nadia Sewelam; Dina Megahed
Journal:  Electron Physician       Date:  2016-09-20

9.  Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis.

Authors:  Elena Palmisani; Nicoletta Solari; Angela Pistorio; Nicolino Ruperto; Clara Malattia; Stefania Viola; Antonella Buoncompagni; Anna Loy; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2007-12-11       Impact factor: 3.054

10.  Physical function assessment tools in pediatric rheumatology.

Authors:  Lakshmi Nandini Moorthy; Margaret Ge Peterson; Melanie J Harrison; Karen B Onel; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2008-06-04       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.